arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Altria Group

MO Health Care Medicinal Chemicals and Botanical Products
$68.88
▲ +0.0% Today
as of Sep 4, 16:51 ET
Last 30 days -7.94% Jul 28 → Sep 04
$63.08 $66.26 $69.44 $72.62 $75.80 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$69.15
High
$69.80
Low
$68.71
Volume
$7M
Avg Vol
$9M
Mkt Cap
$113.1B
P/E (TTM)
16.83
Beta
—
52w High
$77.06
52w Low
$54.70
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 25 ▼ 0
Sep 4 · 18:14 Simply Wall St. neutral
Why Is Altria Group (MO) Adding A Consumer Goods Veteran To Its Board?
Sep 4 · 11:44 24/7 Wall St. neutral
Altria Just Raised Its 6.4% Dividend—Can It Keep Paying?
Sep 3 · 12:54 Barchart neutral
Altria Group Stock: Is MO Underperforming the Consumer Defensive Sector?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$55
$77
63% of range
Avg surprise (last 2)
+5.1%
Avg reaction (last 1)
+1.0%
100% positive
Latest IV / EM
29%
EM ±1.2% · $70 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.00$1.30$1.60$1.91$2.21 Actual $1.00Actual $1.19Actual $1.22Actual $1.21Actual $2.21Actual $1.34Actual $1.23Est $1.17Actual $1.44Est $1.37Actual $1.41Actual $1.30Actual $1.37 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$1.6B$3.3B$4.9B$6.6B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.37 — — — — financials
Tue Mar 31, 2026Mar 2026 $1.30 — — — — financials
Tue Sep 30, 2025Sep 2025 $1.41 — — — — financials
Wed Jul 30, 2025Jun/2025 $1.44 $1.37 +5.1% — — earnings
Tue Apr 29, 2025Mar/2025 $1.23 $1.17 +5.1% — +1.0% earnings
Mon Sep 30, 2024Sep 2024 $1.34 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.21 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.21 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.22 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.19 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.00 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$6.11B$5.43B—$6.07B$6.10B$5.26B—$6.26B
Cost of revenue$1.54B$1.25B—$1.44B$1.44B$1.27B—$1.54B
Gross profit$3.82B$3.51B—$3.81B$3.85B$3.25B—$3.81B
Operating income$3.14B$2.96B—$3.23B$3.23B$1.79B—$3.15B
Net income$2.30B$2.18B—$2.38B$2.38B$1.08B—$2.29B
EPS (diluted)$1.37$1.30—$1.41$1.41$0.63—$1.34

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$2.37B$3.53B$4.47B$3.47B$1.29B$4.73B$3.13B$1.90B
Inventory$1.06B$1.15B$1.07B$1.06B$1.02B$1.06B$1.08B$1.10B
Total current assets$4.02B$5.20B$5.93B$5.12B$2.63B$6.08B$4.51B$3.50B
Total assets$33.37B$34.58B$35.02B$35.01B$32.33B$35.76B$35.18B$34.17B
Long-term debt$22.89B$24.06B$24.14B$24.13B$23.65B$23.43B$23.40B$23.57B
Total liabilities$35.99B$37.74B$38.47B$37.60B$35.54B$39.22B$37.37B$37.59B
Total equity$-2.67B$-3.16B$-3.50B$-2.65B$-3.21B$-3.46B$-2.24B$-3.42B

Implied volatility — last 90 days

22%33%44%54%65% Jun 07 — IV 28% · EM ±2.6%Jun 08 — IV 26% · EM ±2.2%Jun 09 — IV 24% · EM ±1.8%Jun 10 — IV 27% · EM ±1.6%Jun 11 — IV 32% · EM ±1.4%Jun 15 — IV 26% · EM ±1.9%Jun 16 — IV 27% · EM ±1.6%Jun 17 — IV 30% · EM ±1.2%Jun 19 — IV 23% · EM ±2.5%Jun 22 — IV 28% · EM ±2.4%Jun 23 — IV 27% · EM ±1.9%Jun 24 — IV 36% · EM ±2.1%Jun 25 — IV 27% · EM ±1.1%Jun 29 — IV 30% · EM ±7.0%Jun 30 — IV 28% · EM ±6.4%Jul 01 — IV 27% · EM ±6.3%Jul 02 — IV 27% · EM ±6.2%Jul 03 — IV 28% · EM ±6.2%Jul 06 — IV 29% · EM ±6.1%Jul 07 — IV 30% · EM ±6.1%Jul 08 — IV 30% · EM ±6.0%Jul 09 — IV 30% · EM ±5.9%Jul 10 — IV 29% · EM ±5.6%Jul 13 — IV 31% · EM ±5.5%Jul 14 — IV 33% · EM ±5.7%Jul 15 — IV 33% · EM ±5.5%Jul 16 — IV 35% · EM ±5.6%Jul 17 — IV 36% · EM ±5.7%Jul 20 — IV 39% · EM ±5.4%Jul 21 — IV 39% · EM ±5.1%Jul 22 — IV 40% · EM ±5.0%Jul 23 — IV 41% · EM ±4.8%Jul 24 — IV 41% · EM ±4.5%Jul 27 — IV 52% · EM ±4.4%Jul 28 — IV 56% · EM ±4.0%Jul 29 — IV 65% · EM ±3.9%Jul 30 — IV 40% · EM ±1.7%Aug 03 — IV 30% · EM ±2.5%Aug 04 — IV 31% · EM ±2.3%Aug 05 — IV 32% · EM ±1.9%Aug 06 — IV 26% · EM ±1.1%Aug 10 — IV 26% · EM ±2.2%Aug 11 — IV 25% · EM ±1.8%Aug 12 — IV 29% · EM ±1.7%Aug 13 — IV 34% · EM ±1.4%Aug 17 — IV 26% · EM ±2.2%Aug 18 — IV 27% · EM ±1.9%Aug 19 — IV 28% · EM ±1.7%Aug 20 — IV 26% · EM ±1.1%Aug 24 — IV 27% · EM ±2.2%Aug 25 — IV 23% · EM ±1.7%Aug 26 — IV 24% · EM ±1.4%Aug 27 — IV 27% · EM ±1.1%Aug 31 — IV 26% · EM ±2.2%Sep 01 — IV 26% · EM ±1.9%Sep 02 — IV 26% · EM ±1.5%Sep 03 — IV 29% · EM ±1.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in